LifeSiteNews.com

Wednesday July 24, 2002



EUROPEAN PATENT OFFICE BLOCKS HUMAN CLONING ATTEMPT

Korean Raelians claim cloning project underway


SHARE: E-mail E-MAIL  Print PRINT     

MUNICH, July 24, 2002 (LSN.ca) - The European Patent Office, headquarted in the Bavarian capital, said yesterday it had amended an animal cell-manipulation patent granted to the University of Edinburgh in 1999 to prevent its being used for human cloning.

Scotland's premier University and an Australian biotech firm, Stem Cell Sciences, were awarded the patent to genetically alter the cells of "mammals," which could then be used to create embryos.

The patent office admitted a few months later that its language had been unclear, and that officials "had not noticed a reference to human cells in the 235-page document." However, the body requires opposition motions, in this case from Germany, Italy and the Netherlands, in order to move amendments.

Meanwhile, the South Korean Government has started an investigation into a company which claims to have a woman two-months pregnant with a cloned human embryo by a company called BioFusion Tech. The company is an affiliate of the U.S.-based company Clonaid, founded by a religious cult, the Raelian Movement. Raelian members believe life on Earth was created scientifically by extra-terrestrials and supports human cloning as a path to eternal life. In the aftermath of September 11, they declared that cloning would in future make terrorism redundant, as every victim could be cloned and so be re-created.

To read Globe and Mail coverage see:
http://www.globeandmail.com/servlet/ArticleNews/front/RTGAM/20020724/wpate/Front...

To read BBC coverage of the South Korean investigation see:
http://news.bbc.co.uk/2/hi/asia-pacific/2148864.stm

Back to Top Back to Top

SHARE: E-mail E-MAIL  Print PRINT     



MORE NEWS: LifeSiteNews.com Home Page  Last 10 Days   Archives   Special Reports

Copyright © LifeSiteNews.com. This work is licensed under a Creative Commons Attribution-No Derivatives License. You may republish this article or portions of it without request provided the content is not altered and it is clearly attributed to "LifeSiteNews.com". Any website publishing of complete or large portions of original LifeSiteNews articles MUST additionally include a live link to www.LifeSiteNews.com. The link is not required for excerpts. Republishing of articles on LifeSiteNews.com from other sources as noted is subject to the conditions of those sources.